AMN

SEC source: 0001209191-20-025205 · doc4.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

SEC source: 0001209191-20-020608 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,942

F1 · kind: The sale of 14,929 shares of AMN Common Stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $79.703087 per share. These shares were sold in multiple transactions at prices ranging from $67.52 to $89.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-016707 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,013

F1 · price: The price reported in this row represents a weighted average price of $75.2244 per share. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-010266 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,152

F3 · kind: The sale of 603 shares of AMN Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-010106 · doc4.xml · nonDerivative · entry 3

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,013

F3 · shares: The sale of 954 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-010016 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,871

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-010016 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,641

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2019 for the one-year period beginning on January 1, 2019 and ended December 31, 2019. As a result, 25% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-20-010266 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,755

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-010266 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,074

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2019 for the one-year period beginning on January 1, 2019 and ended December 31, 2019. As a result, 25% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-20-010106 · doc4.xml · nonDerivative · entry 2

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,967

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-010106 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,587

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2019 for the one-year period beginning on January 1, 2019 and ended December 31, 2019. As a result, 25% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-20-010030 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,989

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-010030 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,770

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2019 for the one-year period beginning on January 1, 2019 and ended December 31, 2019. As a result, 25% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-20-007744 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,196

F1 · shares: The sale of 7,500 shares of AMN Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $70.069 per share. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.175, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-003909 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,696

F1 · shares: The sale of 7,500 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $64.248 per share. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.055, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-003906 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,013

F1 · kind: The sale of 8,716 shares of Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-003183 · doc4.xml · nonDerivative · entry 1

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,729

F1 · kind: The sale of 1,657 shares of AMN Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-003019 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,152

F1 · kind: The sale of 5,014 shares of Common Stock reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $62.1832 per share. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-003011 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,145

F1 · kind: The sale of 32,721 shares reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $62.0466 per share. These shares were sold in multiple transactions at prices ranging from $61.75 to 62.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-002431 · doc4.xml · derivative · entry 12

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,701

Underlying: Common Stock · 3,701 shares

Expires not disclosed

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F10 · derivative.exercise_date: The RSUs set forth in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002416 · doc4.xml · derivative · entry 12

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,168

Underlying: Common Stock · 6,168 shares

Expires not disclosed

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F10 · derivative.exercise_date: The RSUs set forth in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002414 · doc4.xml · derivative · entry 13

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,663

Underlying: Common Stock · 5,663 shares

Expires not disclosed

F5 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F11 · derivative.exercise_date: The RSUs set forth in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F7 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 9

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,386

F4 · kind: The sale of 25,500 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-20-002431 · doc4.xml · derivative · entry 11

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,009

Underlying: Common Stock · 1,041 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 8

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,166

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 7

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002416 · doc4.xml · derivative · entry 11

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,348

Underlying: Common Stock · 2,418 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 8

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,196

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 7

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,033

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002414 · doc4.xml · derivative · entry 12

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,348

Underlying: Common Stock · 2,418 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F10 · derivative.exercise_date: The RSUs set forth in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F7 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 8

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,886

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 7

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002443 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,866

F2 · kind: Number of shares withheld for tax purposes

SEC source: 0001209191-20-002443 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,685

F1 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2016 for the 3-year period beginning on January 1, 2017 and ended December 31, 2019 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 6, 2020. The Company's Relative TSR measured in the 81st percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-20-002431 · doc4.xml · derivative · entry 10

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,216 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The RSUs set forth in this row were granted on January 4, 2017 and vest on the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 6

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,485

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,949

F3 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2016 for the 3-year period beginning on January 1, 2017 and ended December 31, 2019 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 6, 2020. The Company's Relative TSR measured in the 81st percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,707

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002431 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,159

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002416 · doc4.xml · derivative · entry 10

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,077 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The RSUs set forth in this row were granted on January 4, 2017 and vest on the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 6

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,615

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 5

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,121

F3 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2016 for the 3-year period beginning on January 1, 2017 and ended December 31, 2019 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 6, 2020. The Company's Relative TSR measured in the 81st percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 4

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,876

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002416 · doc4.xml · nonDerivative · entry 3

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,587

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002414 · doc4.xml · derivative · entry 11

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,077 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs set forth in this row were granted on January 4, 2017 and vest on the grantee's provision of three periods of credited service.

F7 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 6

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,057

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 5

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,822

F3 · kind: The acquisition of AMN Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2017. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2016 for the 3-year period beginning on January 1, 2017 and ended December 31, 2019 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 6, 2020. The Company's Relative TSR measured in the 81st percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 4

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,577

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-002414 · doc4.xml · nonDerivative · entry 3

Henderson Ralph · CIK 0001410701 · Pres., Prof. Svc. & Staffing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-002431 · doc4.xml · derivative · entry 9

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,718

Underlying: Common Stock · 1,339 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs set forth in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.